Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.119, No.12, p.762–769, 2018 |
||
Title: Increased lipocalin-2 vs reduced oxytocin in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes | ||
Author: K. O. Tofiq, N. Bulatova, V. Kasabri, M. Suyagh, L. Halaseh, S. Alalawi | ||
Abstract: OBJECTIVES: The neuropeptide hormone- Oxytocin (OXT) and glycoprotein Lipocalin-2 (LCN-2) are strongly associated with cardiometabolic risks of insulin resistance in metabolic syndrome (MetS) and prediabetes (preDM). METHODS: In a cross sectional design we aimed to compare and correlate plasma levels of OXT and LCN-2 and a set of clinical parameters, adiposity indices, atherogenicity indices, and hematological indices in 29 MetS/preDM individuals and 29 non-diabetic MetS subjects vs 30 normoglycemic lean controls. Colorimetric enzymatic assays of biomarkers were procured. RESULTS: LCN-2 concentration (ng/mL) increased significantly in MetS/preDM vs controls. Substantially in MetS recruits (both non-diabetic and pre-diabetics; n = 58); OXT directly correlated with visceral adiposity index (VAI), non-HDL-C/HDL-C ratio, TC/HDL-C ratio, LDL-C/HDL-C ratio, lipid accumulation product (LAP), and atherogenicity index of plasma (AIP). Impressively, LCN-2 correlated proportionally with waist circumference (WC), red cell distribution width (RDW), neutrophils, and neutrophils to lymphocytes ratio (NLR), but inversely with lymphocytes in the 58 (non- and preDM) MetS participants. CONCLUSIONS: These pronounced variations and correlations of OXT and LCN-2 emphasize their putative molecular roles in MetS and preDM pathophysiologies. Thus, OXT and LCN-2 can be surrogate prognostic/diagnostic tools for the MetS/preDM pharmacotherapy/prevention (Tab. 3, Fig. 1, Ref. 44). |
||
Keywords: prediabetes, metabolic syndrome, adiposity indices, hematology indices, atherogenicity indices, oxytocin, lipocalin-2 | ||
Published online: 17-Dec-2018 | ||
Year: 2018, Volume: 119, Issue: 12 | Page From: 762, Page To: 769 | |
doi:10.4149/BLL_2018_139 |
||
|
![]() |
|